Study: New immunotherapy shows promise in targeting pancreatic cancer tumors

Pancreatic cancer is one of the hardest cancers to treat because it's often found very late and there aren't many therapies that work to help control the cancer.

According to the American Cancer Society pancreatic cancer accounts for about 3% of all cancers in the US and about 7% of all cancer deaths.

In most cases pancreatic cancer doesn't respond to immunotherapy, which is a therapy that uses certain parts of a person's immune system to fight the cancer. But a new study is giving hope that a new type of immunotherapy may be able to shrink pancreatic cancer tumors.

Read more of the story here: https://bit.ly/3bf4qBi

➡️Subscribe to 13 ON YOUR SIDE for exclusive content: www.youtube.com/13onyourside
➡️Visit our website: http://www.13onyourside.com

Follow 13 ON YOUR SIDE on social media!

➡️FACEBOOK: http://www.facebook.com/13ONYOURSIDE
➡️TWITTER: http://www.twitter.com/wzzm13
➡️INSTAGRAM: http://www.instagram.com/wzzm13

We stand up for the community. We want to make life better for everyone. We celebrate all that makes West Michigan unique. We are 13 ON YOUR SIDE.